No difference in tumor PD-L1 expression status by HIV status was found, also according to another cohort study, that showed how a high PD-L1 level in NSCLC resulted to be a negative prognostic in HIV-positive but not in HIV-negative individuals. This evidence concerns the gene CD274 and neoplasm.